北京大学学报（医学版） ›› 2020, Vol. 52 ›› Issue (6): 991-994. doi: 10.19723/j.issn.1671-167X.2020.06.001
• 专家笔谈 • 下一篇
成人巨噬细胞活化综合征诊断困境和个体化治疗
贾园,栗占国(
)
- 北京大学人民医院风湿免疫科,北京 100044
摘要：
中图分类号:
- R593.2
| [1] |
Ramos-Casals M, Brito-Zerón P, López-Guillermo A, et al. Adult haemophagocytic Syndrome[J]. Lancet, 2014,383(9927):1503-1516.
doi: 10.1016/S0140-6736(13)61048-X pmid: 24290661 |
| [2] |
黄文秋, 王旖旎, 王晶石, 等. 192例成人噬血细胞淋巴组织细胞增生症患者的临床分析[J]. 中华血液学杂志, 2014,35(9):796-801.
doi: 10.3760/cma.j.issn.0253-2727.2014.09.003 |
| [3] |
Atteritano M, David A, Bagnato G, et al. Haemophagocytic syndrome in rheumatic patients. A systematic review[J]. Eur Rev Med Pharmacol Sci, 2012,16(10):1414-1424.
pmid: 23104659 |
| [4] |
Ahn SS, Yoo BW, Jung SM, et al. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classificationcriteria for macrophage activation syndrome[J]. Semin Arthritis Rheum, 2017,47(2):216-221.
doi: 10.1016/j.semarthrit.2017.02.002 pmid: 28268026 |
| [5] |
Ravelli A, Minoia F, Davì S, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juve-nile idiopathic arthritis: A European League Against Rheumatism / American College of Rheumatology / Paediatric Rheumatology International Trials Organisation Collaborative Initiative[J]. Ann Rheum Dis, 2016,75(3):481-489.
pmid: 26865703 |
| [6] |
Ahn SS, Yoo BW, Jung SM, et al. Application of the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset Still disease[J]. J Rheumatol, 2017,44(7):996-1003.
doi: 10.3899/jrheum.161286 pmid: 28412707 |
| [7] |
Liu AC, Yang Y, Li MT, et al. Macrophage activation syndrome in systemic lupus erythematosus: A multicenter, case-controlstudy in China[J]. Clin Rheumatol, 2018,37(1):93-100.
pmid: 28409239 |
| [8] |
Zhang M, Behrens EM, Atkinson TP, et al. Genetic defects in cytolysis in macrophage activation syndrome[J]. Curr Rheumatol Rep, 2014,16(9):439.
doi: 10.1007/s11926-014-0439-2 pmid: 25086802 |
| [9] |
Wang Y, Wang Z, Zhang J, et al. Genetic features of late onset primary hemophagocytic lymphohistiocytosis in adolescence or adulthood[J]. PLoS One, 2014,9(9):e107386.
doi: 10.1371/journal.pone.0107386 pmid: 25233452 |
| [10] |
Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007,48(2):124-131.
doi: 10.1002/pbc.21039 pmid: 16937360 |
| [11] |
Davì S, Minoia F, Pistorio A, et al. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis[J]. Arthritis Rheumatol, 2014,66(10):2871-2880.
doi: 10.1002/art.38769 pmid: 25044674 |
| [12] |
Ravelli A, Magni-Manzoni S, Pistorio A, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juve-nile idiopathic arthritis[J]. J Pediatr, 2005,146(5):598-604.
doi: 10.1016/j.jpeds.2004.12.016 pmid: 15870661 |
| [13] |
La Rosee P, Horne A, Hines M, et al. Recommendations of the management of hemophagocytic lymphohistiocytosis in adults[J]. Blood, 2019,133(23):2465-2477.
doi: 10.1182/blood.2018894618 pmid: 30992265 |
| [14] |
Tada Y, Inokuchi S, Maruyama A, et al. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still’s disease?[J]. Rheumatol Int, 2019,39(1):97-104.
doi: 10.1007/s00296-018-4114-1 pmid: 30051293 |
| [15] |
Minoia F, Bovis F, Davì S, et al. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis[J]. Ann Rheum Dis, 2019,78(10):1357-1362.
doi: 10.1136/annrheumdis-2019-215211 pmid: 31296501 |
| [16] | Wang R, Li T, Ye S, et al. Application of MS score in macrophage activation syndrome patients associated with adult onset Still’s disease [J/OL]. Ann Rheum Dis, (2019-10-14) [2020-06-25]. doi: 10.1136/annrheumdis-2019-216286. |
| [17] | 姚海红, 王旖旎, 张霞, 等. 67例成人巨噬细胞活化综合征的临床特征及治疗转归[J]. 北京大学学报(医学版), 2019,51(6):996-1002. |
| [18] |
Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy[J]. Nat Rev Rheumatol, 2016,12(5):259-268.
doi: 10.1038/nrrheum.2015.179 pmid: 27009539 |
| [19] |
Weiss ES, Girard-Guyonvarc’h C, Holzinger D, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome[J]. Blood, 2018,131(13):1442-1455.
doi: 10.1182/blood-2017-12-820852 pmid: 29326099 |
| [1] | 李熠,尉华杰,邱立新. 种植体折裂的临床分型与临床治疗方案[J]. 北京大学学报（医学版）, 2022, 54(1): 126-133. |
| [2] | 李伟浩,李伟,张学民,李清乐,焦洋,张韬,蒋京军,张小明. 去分支杂交手术和传统手术治疗胸腹主动脉瘤的结果比较[J]. 北京大学学报（医学版）, 2022, 54(1): 177-181. |
| [3] | 孟广艳,张筠肖,张渝昕,刘燕鹰. IgG4相关性疾病中枢神经系统受累的临床特点分析[J]. 北京大学学报（医学版）, 2021, 53(6): 1043-1048. |
| [4] | 张学武. 痛风关节炎治疗中几个备受关注的问题[J]. 北京大学学报（医学版）, 2021, 53(6): 1017-1019. |
| [5] | 翟莉,邱楠,宋惠. 多中心网状组织细胞增生症1例[J]. 北京大学学报（医学版）, 2021, 53(6): 1183-1187. |
| [6] | 王飞,朱翔,贺蓓,朱红,沈宁. 自发缓解的滤泡性细支气管炎伴非特异性间质性肺炎1例报道并文献复习[J]. 北京大学学报（医学版）, 2021, 53(6): 1196-1200. |
| [7] | 朱正达,高岩,何汶秀,方鑫,刘洋,魏攀,闫志敏,华红. 红色诺卡氏菌细胞壁骨架治疗糜烂型口腔扁平苔藓的疗效及安全性[J]. 北京大学学报（医学版）, 2021, 53(5): 964-969. |
| [8] | 洪鹏,田晓军,赵小钰,杨飞龙,刘茁,陆敏,赵磊,马潞林. 肾移植术后双侧乳头状肾癌1例[J]. 北京大学学报（医学版）, 2021, 53(4): 811-813. |
| [9] | 邱敏,费月阳,邓绍晖,刘承,卢剑,何为,陆敏,田晓军,张树栋,马潞林. 后肾腺瘤的诊治经验及文献回顾[J]. 北京大学学报（医学版）, 2021, 53(2): 417-419. |
| [10] | 孟圆,张丽琪,赵雅宁,柳登高,张祖燕,高岩. 67例上颌根尖周囊肿的三维影像特点分析[J]. 北京大学学报（医学版）, 2021, 53(2): 396-401. |
| [11] | 王昱,邓雪蓉,季兰岚,张晓慧,耿研,张卓莉. 超声检测痛风患者肌腱受累的危险因素和诊断价值[J]. 北京大学学报（医学版）, 2021, 53(1): 143-149. |
| [12] | 高璐,谷岩. 中国人群腭中缝形态特点分期与Demirjian牙龄的相关性[J]. 北京大学学报（医学版）, 2021, 53(1): 133-138. |
| [13] | 袁源,郎宁,袁慧书. CT能谱曲线在脊柱转移瘤和感染性病变中的鉴别诊断价值[J]. 北京大学学报（医学版）, 2021, 53(1): 183-187. |
| [14] | 周培茹, 蒋析, 华红. 口腔黏膜病患者口腔种植的时机及注意事项[J]. 北京大学学报（医学版）, 2021, 53(1): 5-8. |
| [15] | 康琦,张继新,高莹,张俊清,郭晓蕙. 100例甲状腺嗜酸细胞腺瘤的诊治分析[J]. 北京大学学报（医学版）, 2020, 52(6): 1098-1101. |
|
